Key facts
- This page summarizes AMGEN INC's Form 4 filing for BeiGene, Ltd. (ONC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Sep 2021, 19:27.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
This transaction was made pursuant to that Share Purchase Agreement, dated as of September 24, 2020, as amended, by and between the Reporting Person and the Issuer.
Footnote F2
The price reported is the volume weighted average price on the NASDAQ Stock Market LLC of one American Depositary Share ("ADS") of the Issuer for the ninety calendar days preceding August 31, 2021.
Footnote F3
As each ADS represents 13 Ordinary Shares of the Issuer, the reported securities represent 246,269,426 Ordinary Shares.